|
Volumn 115, Issue 1-2, 2009, Pages 230-233
|
Long term augmentation with T3 in refractory major depression
|
Author keywords
Augmentation; L thyroxine; Major depression; Refractory depression; T3; Thyroid
|
Indexed keywords
AMFEBUTAMONE;
AMITRIPTYLINE;
AMPHETAMINE;
ARIPIPRAZOLE;
BUSPIRONE;
CARBAMAZEPINE;
CITALOPRAM;
CLONAZEPAM;
DEXAMPHETAMINE;
ESCITALOPRAM;
FLUOXETINE;
GABAPENTIN;
LAMOTRIGINE;
LIOTHYRONINE;
LORAZEPAM;
MIRTAZAPINE;
MODAFINIL;
OXCARBAZEPINE;
PAROXETINE;
PRAMIPEXOLE;
SERTRALINE;
THYROTROPIN;
TRANYLCYPROMINE;
TRAZODONE;
TRIAZOLAM;
VENLAFAXINE;
ZOLPIDEM;
ADULT;
ANXIETY;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL GLOBAL IMPRESSION SCALE;
DRUG DOSE ESCALATION;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
FEMALE;
HEART ATRIUM FIBRILLATION;
HEAT INTOLERANCE;
HUMAN;
HYPERTHYROIDISM;
IRRITABILITY;
MAJOR DEPRESSION;
MALE;
OSTEOPENIA;
OSTEOPOROSIS;
PRIORITY JOURNAL;
SIDE EFFECT;
SYMPTOM;
TREATMENT DURATION;
TREMOR;
ADULT;
ANTIDEPRESSIVE AGENTS;
DEPRESSIVE DISORDER, MAJOR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
LONG-TERM CARE;
MALE;
MIDDLE AGED;
PERSONALITY ASSESSMENT;
SEX FACTORS;
TRIIODOTHYRONINE;
|
EID: 62649107130
PISSN: 01650327
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jad.2008.09.022 Document Type: Article |
Times cited : (21)
|
References (6)
|